InvestorsHub Logo
Followers 22
Posts 587
Boards Moderated 0
Alias Born 08/19/2020

Re: tcm55 post# 26856

Friday, 10/16/2020 11:58:01 AM

Friday, October 16, 2020 11:58:01 AM

Post# of 44690
Because with a strong P-Value, it becomes unethical to continue trials.

The P-Value determines the possibility that the results we are seeing are wrong. The stronger the P-value, the less chance our results are a mistake. A P-Value of P<=0.0001 would be sooooo strong, that it would be unethical to continue trials. In other words, if you are THAT CERTAIN the drug works, then stop the trial and quick giving the dying patients a placebo, because they will continue to die at a high rate, so we need to stop and actually give them RLF100.

You asked: "Why NOT finish recruitment and collect firmer data?"

Because trial placebo will continue to let people die.

Disclaimer: I am not a professional advisor. Seek professional advice before investing or trading. I take risky positions and do not advise anyone to follow my opinions or actions.